New video from Institute of Medicine on "What you need to know about infectious disease" which is useful and fortunately includes some information about things other than infectious diseases.
It is based on this booklet.
Showing posts with label infectious disease. Show all posts
Showing posts with label infectious disease. Show all posts
Wednesday, November 9, 2011
Thursday, September 1, 2011
Structures, structures, and structures: Structural genomics of infectious disease drug targets: the SSGCID
Cool new data set available for those studying infectious disease. See the paper: Structural genomics of infectious disease drug targets: the SSGCID
This is a large scale effort to determine crystal structure of importance for infectious disease studies. And there is a whole series of papers coming out in "Acta Crystallographica Section F Structural Biology and Crystallization Communications"
Plus all the papers about these structures are freely available (though I note - they refer to these as "Open Access" but really they mean "Available at no charge"
Examples of papers include:
Also see their press release here.
This is a large scale effort to determine crystal structure of importance for infectious disease studies. And there is a whole series of papers coming out in "Acta Crystallographica Section F Structural Biology and Crystallization Communications"
Plus all the papers about these structures are freely available (though I note - they refer to these as "Open Access" but really they mean "Available at no charge"
Examples of papers include:
- Gene design, cloning and protein-expression methods for high-value targets at the Seattle Structural Genomics Center for Infectious Disease
- Immobilized metal-affinity chromatography protein-recovery screening is predictive of crystallographic structure success
- Structures of phosphopantetheine adenylyltransferase from Burkholderia pseudomallei
- Structures of a putative -class glutathione S-transferase from the pathogenic fungus Coccidioides immitis
And many more.
Also see their press release here.
Subscribe to:
Posts (Atom)